These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Cardiac resynchronisation therapy as a cause of the electrical storm]. Krupa W; Lackowski J; Sielski S; Dobosiewicz R; Kubica J Kardiol Pol; 2007 Nov; 65(11):1350-3. PubMed ID: 18058584 [TBL] [Abstract][Full Text] [Related]
65. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade. Kantharia BK; Patel JA; Nagra BS; Ledley GS Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367 [TBL] [Abstract][Full Text] [Related]
66. Implantation of a biventricular implantable cardioverter defibrillator via the femoral vein. Jourdier L; Swinburn J; Roberts D; Clague J Pacing Clin Electrophysiol; 2007 Apr; 30(4):571-2. PubMed ID: 17437585 [TBL] [Abstract][Full Text] [Related]
67. I have an implantable cardioverter defibrillator (ICD), and I've been taking fish oil supplements because I had heard of their potential heart benefits. However, I recently read they might not be safe for people with ICDs. Should I stop taking them? Johns Hopkins Med Lett Health After 50; 2005 Oct; 17(8):8. PubMed ID: 16247866 [No Abstract] [Full Text] [Related]
68. T-wave oversensing by an implantable cardioverter defibrillator after successful ablation of idiopathic ventricular fibrillation. Strohmer B; Schernthaner C; Pichler M Pacing Clin Electrophysiol; 2006 Apr; 29(4):431-5. PubMed ID: 16650276 [TBL] [Abstract][Full Text] [Related]
69. Ventricular tachycardia and ventricular fibrillation. Srivathsan K; Ng DW; Mookadam F Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116 [TBL] [Abstract][Full Text] [Related]
70. Quinidine ceases electrical storm in an ablated patient with an implantable cardioverter-defibrillator: an old lady in the modern era. Georgiadou P; Iliodromitis EK; Theodorakis GN; Kremastinos DT Int J Cardiol; 2006 Oct; 113(1):129-31. PubMed ID: 16318889 [No Abstract] [Full Text] [Related]
72. Implantation of an implantable cardioverter-defibrillator in a patient on chronic hemodialysis. Pürerfellner H; Nesser HJ; Aichinger J; Stummvoll K; Steinbach K Clin Nephrol; 1993 Feb; 39(2):112-3. PubMed ID: 8448914 [No Abstract] [Full Text] [Related]
73. How to avoid inappropriate therapy. Israel CW Curr Opin Cardiol; 2008 Jan; 23(1):65-71. PubMed ID: 18281830 [TBL] [Abstract][Full Text] [Related]
74. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E; Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252 [TBL] [Abstract][Full Text] [Related]
75. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator. Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756 [TBL] [Abstract][Full Text] [Related]